(±)-Rotigotine

Modify Date: 2024-01-02 19:40:26

(±)-Rotigotine Structure
(±)-Rotigotine structure
Common Name (±)-Rotigotine
CAS Number 92206-54-7 Molecular Weight 315.47
Density 1.2±0.1 g/cm3 Boiling Point 470.1±45.0 °C at 760 mmHg
Molecular Formula C19H25NOS Melting Point N/A
MSDS N/A Flash Point 238.1±28.7 °C

 Use of (±)-Rotigotine


(Rac)-Rotigotine (N-0437) is a racemate of Rotigotine. Rotigotine is a full agonist of?dopamine receptor, a partial agonist of the?5-HT1A receptor, and an antagonist of the?α2B-adrenergic receptor, with?Kis of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.

 Names

Name 6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol
Synonym More Synonyms

 (±)-Rotigotine Biological Activity

Description (Rac)-Rotigotine (N-0437) is a racemate of Rotigotine. Rotigotine is a full agonist of?dopamine receptor, a partial agonist of the?5-HT1A receptor, and an antagonist of the?α2B-adrenergic receptor, with?Kis of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.
Related Catalog
Target

Ki: Dopamine receptor; 5-HT receptor[1][2]

In Vitro Rotigotine has a 10-fold selectivity for D3 (pKi=9.2) receptors compared with D2, D4 and D5 (pKi=8.5-8.0) and a 100-fold selectivity compared with D1 receptors (pKi=7.2). In functional studies, Rotigotine behaves as full agonist at all dopamine receptors but notably the potency for stimulation of D1 receptors is similar to that for D2 and D3 receptors (pEC50?respectively: 9.0, 9.4-8.6, 9.7)[1]. Rotigotine (10 μM) decreases the number of THir neurons by 40% in primary mesencephalic cell culture. Rotigotine (0.01 μM) slightly protects dopaminergic neurons against MPP+?toxicity, significantly protects dopaminergic neurons against rotenone-induced cell death, and significantly inhibits ROS production by rotenone[4]. .
References

[1]. Wood M, et al. Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. Br J Pharmacol. 2015 Feb;172(4):1124-35.  

[2]. Scheller D, et al. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):73-86.  

[3]. Fenu S, et al. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors. Eur J Pharmacol. 2016 Oct 5;788:183-91.  

[4]. Radad K, et al. Neuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture. Folia Neuropathol. 2014;52(2):179-86.  

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Boiling Point 470.1±45.0 °C at 760 mmHg
Molecular Formula C19H25NOS
Molecular Weight 315.47
Flash Point 238.1±28.7 °C
Exact Mass 315.165680
PSA 51.71000
LogP 4.96
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.611

 Safety Information

HS Code 2934999090

 Synthetic Route

~%

(±)-Rotigotine Structure

(±)-Rotigotine

CAS#:92206-54-7

Literature: SHAN DONG LUYE PHARMACEUTICAL CO., LTD.; Meng, Qingguo; Yang, Mina; Wang, Tao; Wang, Qilin; Li, Jun; Ruan, Zheng Patent: US2014/121380 A1, 2014 ; Location in patent: Paragraph 0059 ;

~%

(±)-Rotigotine Structure

(±)-Rotigotine

CAS#:92206-54-7

Literature: Journal of medicinal chemistry, , vol. 39, # 21 p. 4233 - 4237

~%

(±)-Rotigotine Structure

(±)-Rotigotine

CAS#:92206-54-7

Literature: Journal of medicinal chemistry, , vol. 39, # 21 p. 4233 - 4237

~%

(±)-Rotigotine Structure

(±)-Rotigotine

CAS#:92206-54-7

Literature: Journal of medicinal chemistry, , vol. 39, # 21 p. 4233 - 4237

~%

(±)-Rotigotine Structure

(±)-Rotigotine

CAS#:92206-54-7

Literature: Journal of medicinal chemistry, , vol. 39, # 21 p. 4233 - 4237

 Customs

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

6-(Propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol
6-{Propyl[2-(2-thienyl)ethyl]amino}-5,6,7,8-tetrahydro-1-naphthalenol
5-hydroxy-2-(N-n-propyl-N-2-ethylthienyl-amino)tetralin
1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-
6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol
UNII:5QTR54Z0E1
rotigotine transdermal patch
N-0437
ent-Rotigotine
ROTIGOTINE, (±)-
1-Naphthalenol, 5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-
(-)-5,6,7,8-tetrahydro-6-[propyl[2-(thien-2-yl)ethyl]-amino]-1-naphthol
6-{Propyl[2-(2-thienyl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol
2-(N-propyl-N-(2-thiofuranyl)-2'-ethylamino)-5-hydroxy-1,2,3,4-tetrahydronaphthalene
[3H]-N 0437